Autopsy report · NCT01189019

HiPED - High Dose Lucentis for Persistent Pigment Epithelial Detachments in Age-related Macular Degeneration

“Drug dose became unavailable”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 years 7 months before it stopped.
• 40 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Anne Fung MD

Sponsor type

University, hospital or other

Conditions

Wet Macular Degeneration; Macular Degeneration; Retinal Pigment Epithelial Detachment

Interventions

ranibizumab; ranibizumab

Participants

40

Sites

3

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.